Open AccessA phase II Study of TAS-117 in Patients with Advanced Solid Tumors Harboring Germline PTEN -Inactivating Mutations
Author(s) -
Jordi Rodón,
Pauline Funchain,
Theodore W. Laetsch,
HendrikTobias Arkenau,
Alice Hervieu,
Christian F. Singer,
Yonina R. MurcianoGoroff,
Sant P. Chawla,
Kristin Anthony,
Ikuo Yamamiya,
Mei Liu,
AbdelBaset Halim,
Karim A. Benhadji,
Osamu Takahashi,
Suzette Delaloge
Publication year - 2022
Publication title -
future oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.857
H-Index - 72
eISSN - 1744-8301
pISSN - 1479-6694
DOI - 10.2217/fon-2022-0305
Subject(s) - pten , germline , medicine , cancer research , germline mutation , oncology , mutation , genetics , gene , biology , pi3k/akt/mtor pathway , apoptosis
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom